arrow
H

Hiroaki Takaya

Nara Medical University
H指数:24
被引数:2,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Effects of Nalmefene on Alcohol Consumption, Liver Function, and Gut Microbiota in Patients With Alcohol-Related Liver Disease

纳美芬对酒精相关肝病患者酒精摄入、肝功能及肠道微生物群的长期影响

2026-09-070
PRE
Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in Cirrhosis

脂多糖结合蛋白和可溶性甘露糖受体作为肝硬化急性肾损伤的生物标志物

2026-06-080
PRE
Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response

肌酐/胱抑素C比值作为丙型肝炎相关肝硬化患者实现持续病毒学应答后肌少症替代标志物

2026-02-180
OAAI
The Ratio of von Willebrand Factor to ADAMTS13 May Improve Sarcopenia Identification in Patients with Liver Cirrhosis: A Retrospective Study

von Willebrand因子与ADAMTS13的比值可能改善肝硬化患者肌肉减少症的诊断:一项回顾性研究

2026-01-010
OA
Marked Increase in Zinc Concentration of Ascitic Fluid After Cell-free and Concentrated Ascites Reinfusion Therapy in Patients With Cirrhotic Refractory Ascites: A Retrospective Observational Study
IN VIVO
IF1.8
2025-11-010
PRE
Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD

肌酐-胱抑素C比值联合FIB-4和ELF在MASLD非侵入性纤维化评估中的应用

2025-09-300
OAAI
Initial Experience With Nalmefene in Alcohol-Related Liver Disease: A Real-World Retrospective Study

纳美芬治疗酒精性肝病的初步经验:一项真实世界回顾性研究

2025-08-160
PRE
Recombinant human ADAMTS13 attenuates LPS-induced acute kidney injury and renal microangiopathy in murine advanced liver fibrosis by cleaving vWF

重组人ADAMTS13通过切割vWF,减轻小鼠晚期肝纤维化中LPS诱导的急性肾损伤和肾微血管病变。

2025-06-090
OAAI
Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitis
2025-04-010
PRE
Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis
2024-06-051
PRE
Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID-19 severity in patients with nonalcoholic fatty liver disease

天冬氨酸转氨酶与血小板比率指数可作为非酒精性脂肪肝患者新型冠状病毒肺炎严重程度的生物标志物

2023-07-311
PRE
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic Cirrhosis

血红蛋白和内毒素水平预测酒精性肝硬化患者肌肉减少症的发生

2023-06-293
OAAI
Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis

血红蛋白水平作为肝硬化患者肌肉减少症的替代指标

2023-04-284
PRE